Here is what I don't get. They still had other avenues out there. They had Excellagen, they had the deals in the states, they had the cancer research, they had diabetes. They had all of those and yet this still all happened. They could have pushed heavily for investment in those areas and with everything going on, over the last few years could have weathered everything and this is where we are at.
(1)
(0)
Generex Biotechnology Corp. (GNBTQ) Stock Research Links